Division of Hematology/Oncology, Department of Internal Medicine, Kameda Medical Center, 929 Higashi-chou, Kamogawa, Chiba, 296-8602, Japan.
Int J Hematol. 2022 Oct;116(4):579-585. doi: 10.1007/s12185-022-03397-7. Epub 2022 Jul 10.
Chylous effusion is associated with lymphatic obstruction or leakage in mediastinal or abdominal lymph nodes, and is a rare but troublesome complication in patients with malignant lymphomas. Although there is no standard of care, it is often treated with simultaneous chemotherapeutic and non-chemotherapeutic interventions. Here, we describe the cases of five patients with lymphoma-associated chylothorax with the aim of clarifying an effective treatment strategy. All patients achieved a partial response or better for lymphoma. All patients underwent interventional radiology (IVR) procedures, including lymphangiography (LAG) and thoracic duct embolization (TDE). Complete resolution of chylothorax was eventually achieved by IVR procedures or pleurodesis in all patients. No patients experienced serious adverse events related to LAG/TDE. Treatment of chylous effusion required months for most patients (range: 0.2-4.8 months). Our data suggest that a combination of chemotherapy and LAG/TDE is effective for refractory lymphoma-related chylous effusion.
乳糜胸与纵隔或腹部淋巴结中的淋巴阻塞或泄漏有关,是恶性淋巴瘤患者中罕见但麻烦的并发症。虽然没有标准的治疗方法,但通常同时采用化疗和非化疗干预措施进行治疗。在这里,我们描述了 5 例淋巴瘤相关乳糜胸患者的病例,旨在阐明有效的治疗策略。所有患者的淋巴瘤均达到部分缓解或更好的效果。所有患者均接受了介入放射学(IVR)程序,包括淋巴管造影(LAG)和胸导管栓塞(TDE)。所有患者最终通过 IVR 程序或胸膜固定术完全解决了乳糜胸问题。没有患者出现与 LAG/TDE 相关的严重不良事件。大多数患者(范围:0.2-4.8 个月)需要数月时间才能治愈乳糜胸。我们的数据表明,化疗联合 LAG/TDE 对难治性淋巴瘤相关乳糜胸有效。